This complexity is influenced by factors including tumor mutational status, molecular subtype, and treatment conditions, with macrophages in IDH wild-type gliomas showing a tendency toward immunosuppressive phenotypes driven by cytokines like midkine, ANXA1, and GPNMB [15]. The gene discussed is IDH1; the disease is glioma.